Haemonetics (HAE) Goodwill (2010 - 2026)

Haemonetics' Goodwill history runs 17 years deep, the most recent figure standing at $656.4 million for Q1 2026.

• On a quarterly basis, Goodwill rose 8.62% year-over-year to $656.4 million in Q1 2026; TTM through Mar 2026 was $656.4 million, a 8.62% increase from a year earlier, with the FY2026 full-year figure at $656.4 million, up 8.62% from the prior year.
• Goodwill grew to $656.4 million in Q1 2026 per HAE's latest filing, from $606.8 million in the prior quarter.
• Across five years, Goodwill topped out at $656.4 million in Q1 2026 and bottomed at $465.0 million in Q4 2022.
• The 5-year median for Goodwill is $560.0 million (2023), against an average of $542.6 million.
• Across the five-year window, Goodwill soared 657.38% in 2022 and declined 1.63% in 2025, its largest moves.
• Year by year, Goodwill stood at $466.1 million in 2022, then grew by 19.07% to $555.0 million in 2023, then gained by 9.06% to $605.3 million in 2024, then climbed by 0.26% to $606.8 million in 2025, then gained by 8.16% to $656.4 million in 2026.
• Per Business Quant, the three latest HAE Goodwill figures stand at $656.4 million (Q1 2026), $606.8 million (Q4 2025), and $606.1 million (Q3 2025).